Search results
M&M Q1: A Marginal Decline in Profit | India Infoline
India Infoline· 2 hours agoMahindra & Mahindra (M&M) reported a marginal 5.3% year-on-year decline in standalone net profit for the first quarter of this fiscal year, amounting to ₹2,613 crore, down ...
Starbucks Q3 2024: operational gains amid sales decline
Retail Insight Network· 57 minutes agoSegment performance North America: Revenues increased 1% to $6.8bn, driven by a 5% increase in new ...
Maruti Suzuki Q1 Results: Profit soars 47% YoY to Rs 3,650 crore, beats estimates - The Economic...
The Economic Times· 3 hours agoIndia's largest carmaker, Maruti Suzuki, reported a 46.9% year-on-year (YoY) increase in standalone profit for the June quarter, reaching Rs 3,650 crore, surpassing the Street estimate of Rs 3,467 crore.
Ambuja Cements net dips 30% on weak demand, lower realisation
The Hindu· 2 hours agoAmbuja Cements reports decrease in net profit due to lower realizations, aims for cost reduction and capacity expansion.
Zomato share price soars 173% in last 1 year; Axis Securities says buy the stock; here’s why | Stock...
Livemint· 2 hours agoAxis Securities has initiated coverage on India's food delivery giant Zomato with a buy call. The...
10 Best Fish for Beginners Who Aren't Sure Where to Start
PetHelpful· 49 minutes agoAs with most viviparous fish, look out for live babies, and keep at least 2-3 female swords for...
An order from Tata Motors takes shares of this ₹500 crore company up by 10% - CNBC TV18
CNBC TV18· 8 hours agoShares of auto parts manufacturer Autoline Industries Ltd. surged as much as 11% on Wednesday after...
Maruti Suzuki profit jumps 47% in Q1
rediff.com· 3 hours agoMaruti Suzuki India on Wednesday reported a 47 per cent jump in its net profit to Rs 3,650 crore for the April-June quarter on account of cost reduction...
Multibagger Stock, 700% RETURN In 3 Years: FII-backed SEIL Shares Hit 20% Upper Circuit
Times Now· 4 hours agoShanti Educational Initiatives Ltd (SEIL) share price hit an intraday high of Rs 109.64 per share on...
Diamyd Medical to continue Phase III trial of type 1 diabetes treatment
Clinical Trials Arena· 3 hours agoIt enrolled individuals aged 12 to 29 years old, who were recently diagnosed with T1D and carry the...
